{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:10:42Z","timestamp":1771326642439,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12350-018-1196-9","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T15:59:39Z","timestamp":1517241579000},"page":"1566-1568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["123I-mIBG: Simplicity and reproducibility"],"prefix":"10.1016","volume":"26","author":[{"given":"Kevin","family":"Curl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-1196-9_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ajhp\/55.7.676","article-title":"Catecholamines and their blockade in congestive heart failure","volume":"55","author":"White","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1007\/s12350-018-1196-9_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.pa.08.040168.002113","article-title":"False adrenergic transmitters","volume":"8","author":"Kopin","year":"1968","journal-title":"Annu Rev Pharmacol"},{"key":"10.1007\/s12350-018-1196-9_bib3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/0735-1097(88)92608-3","article-title":"Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy","volume":"12","author":"Schofer","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1007\/s12350-018-1196-9_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12350-012-9655-1","article-title":"Cardiac autonomic imaging with SPECT tracers","volume":"20","author":"Travin","year":"2012","journal-title":"Journal of Nuclear Cardiology"},{"key":"10.1007\/s12350-018-1196-9_bib5","first-page":"349","article-title":"Radiolabeled adrenergic neuron-blocking agents: Adrenomedullary imaging with [131I]iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib6","first-page":"129","article-title":"Myocardial imaging in man with I-123 meta-iodobenzylguanidine","volume":"22","author":"Kline","year":"1981","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.78.5.1192","article-title":"Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy","volume":"78","author":"Henderson","year":"1988","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-1196-9_bib8","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12149-015-0989-z","article-title":"Validity of the mediastinum as a reference region to evaluate cardiac accumulation of iodine-123 metaiodobenzylguanidine","volume":"29","author":"Inoue","year":"2015","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib10","first-page":"845","article-title":"Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: A 123I-mIBG scintigraphic study","volume":"41","author":"Agostini","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1067\/mnc.2002.127717","article-title":"Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine","volume":"9","author":"Gerson","year":"2002","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1196-9_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0735-1097(02)02700-6","article-title":"Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study","volume":"41","author":"Yamada","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1196-9_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00259-008-0976-x","article-title":"How to use myocardial 123I-mIBG scintigraphy in chronic heart failure","volume":"36","author":"Agostini","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1196-9_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00259-007-0611-2","article-title":"Variations in 123I-metaiodobenzylguanidine (mIBG) late heart mediastinal ratios in chronic heart failure: A need for standardisation and validation","volume":"35","author":"Verberne","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1196-9_bib15","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (mIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1196-9_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11886-010-0157-y","article-title":"Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: Its affecting factors and potential corrections","volume":"13","author":"Chen","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"10.1007\/s12350-018-1196-9_bib17","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1196-9_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2967\/jnumed.115.156406","article-title":"(1)(2)(3)I-mIBG Imaging for prediction of mortality and potentially fatal events in heart failure: The ADMIRE-HFX study","volume":"56","author":"Narula","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1253\/circj.CJ-88-0019","article-title":"Guidelines for clinical use of cardiac nuclear medicine (JCS 2010)\u2014Digest version","volume":"76","year":"2012","journal-title":"Circ J"},{"key":"10.1007\/s12350-018-1196-9_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0002-8703(93)91056-K","article-title":"Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy","volume":"126","author":"Gill","year":"1993","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-018-1196-9_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12350-013-9714-2","article-title":"Significance of I-123 metaiodobenzylguanidine ((1)(2)(3)I-mIBG) lung activity in subjects with heart failure in comparison to healthy control subjects","volume":"20","author":"Gerson","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1196-9_bib22","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.amjcard.2008.01.030","article-title":"Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy","volume":"101","author":"Kamiyoshi","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-018-1196-9_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0735-1097(88)90351-8","article-title":"Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: A comparison with cardiac catheterization","volume":"12","author":"Kaul","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1196-9_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00259-012-2180-2","article-title":"Reproducibility of planar (123)I-meta-iodobenzylguanidine (mIBG) myocardial scintigraphy in patients with heart failure","volume":"39","author":"Veltman","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1196-9_bib25","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00259-013-2461-4","article-title":"Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure","volume":"40","author":"Pellegrino","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1196-9_bib26","doi-asserted-by":"crossref","unstructured":"Bateman T, Ananthasubramaniam K, Berman D, Gerson M, Gropler R, Henzlova M, et al. Reliability of the 123I-mIBG heart\/mediastinum ratio: Results of a multicenter test\u2013retest reproducibility study. J Nucl Cardiol 2018. https:\/\/doi.org\/10.1007\/s12350-017-1183-6.","DOI":"10.1007\/s12350-017-1183-6"},{"key":"10.1007\/s12350-018-1196-9_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/ehm048","article-title":"Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol","volume":"28","author":"Kasama","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-1196-9_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/hrt.2005.062463","article-title":"Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"key":"10.1007\/s12350-018-1196-9_bib29","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2967\/jnumed.107.045427","article-title":"Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure","volume":"48","author":"Kasama","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1196-9_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/europace\/eum081","article-title":"Improvement in cardiac adrenergic function post biventricular pacing for heart failure","volume":"9","author":"Gould","year":"2007","journal-title":"Europace"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-1196-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1196-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123063043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123063043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1196-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:05:47Z","timestamp":1761026747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123063043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1071358123063043"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-1196-9","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"123I-mIBG: Simplicity and reproducibility","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-1196-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}